| Oppenheimer Maintains Attractive Outlook And Price Target On China Biotech ... - Benzinga |
|
|
Benzinga"We continue to like the 3SBio story for its distant leadership position in the nephrology/cancer supportive care markets. We believe the promising prospect ... read more |